Is Ultragenyx Pharmaceutical Inc. (RARE) a Buy, Sell, or Hold?
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$32.03 USD
-$1.19 (-3.58%)
- Volume
- 1.11M
- Average Volume
- 2.2M
- Market Capitalization
- $3.15B
- P/E Ratio
- -5.24
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $39.89
- Year Low
- $18.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.02
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-25.5% DOWNSIDE
$43.00 Price Target
UPSIDE/DOWNSIDE HIGH
-52.2% DOWNSIDE
$67.00 Price Target High
UPSIDE/DOWNSIDE LOW
6.8% UPSIDE
$30.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Eliana Merle | $43 | $24.53 | 2026-04-29 05:43 AM | 75.3% |
| Leerink Partners | Joseph Schwartz | $60 | $21.3618 | 2026-03-12 10:39 AM | 180.9% |
| Evercore ISI | Gavin Clark-Gartner | $34 | $20.14 | 2026-02-18 08:17 AM | 68.8% |
| H.C. Wainwright | Raghuram Selvaraju | $50 | $20.52 | 2026-02-17 06:11 AM | 143.7% |